These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35962518)

  • 1. Vitiligo Impact Scale (VIS)-22: A measure of the psycho-social burden of vitiligo.
    Gupta V; Ramam M
    Indian J Dermatol Venereol Leprol; 2022; 88(5):691-695. PubMed ID: 35962518
    [No Abstract]   [Full Text] [Related]  

  • 2. Determining the minimal important change scores of the Vitiligo Impact Scale (VIS)-22 and Dermatology Life Quality Index (DLQI) scores in Indian patients with vitiligo using anchor- and distribution-based approaches.
    Gupta V; Taneja N; Sati HC; Sreenivas V; Ramam M
    Br J Dermatol; 2020 Aug; 183(2):393-394. PubMed ID: 32119113
    [No Abstract]   [Full Text] [Related]  

  • 3. Transcultural assessment of quality of life in patients with vitiligo.
    Hans A; Reddy KA; Black SM; Thomas J; Martinez-Luna O; McKesey J; Hynan LS; Pandya AG
    J Am Acad Dermatol; 2022 May; 86(5):1114-1116. PubMed ID: 33852927
    [No Abstract]   [Full Text] [Related]  

  • 4. Vitiligo and quality of life: the dark face of whiteness.
    Ezzedine K; Eleftheriadou V
    Br J Dermatol; 2018 Jan; 178(1):28-29. PubMed ID: 29357599
    [No Abstract]   [Full Text] [Related]  

  • 5. Family vitiligo impact scale: A scale to measure the quality-of-life of family members of patients with vitiligo.
    Agrawal S; Satapathy S; Gupta V; Sreenivas V; Khaitan BK; Ramam M
    Indian J Dermatol Venereol Leprol; 2021; 88(1):32-39. PubMed ID: 34379960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Vitiligo Impact Patient Scale (VIPs): Development and Validation of a Vitiligo Burden Assessment Tool.
    Salzes C; Abadie S; Seneschal J; Whitton M; Meurant JM; Jouary T; Ballanger F; Boralevi F; Taieb A; Taieb C; Ezzedine K
    J Invest Dermatol; 2016 Jan; 136(1):52-8. PubMed ID: 26763423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitiligo or Vitiligo-like Hypopigmentation Associated with Imiquimod Treatment of Condyloma Acuminatum: Not a Casual Event.
    Long FQ; Zhao LS; Qian YH
    Chin Med J (Engl); 2017 Feb; 130(4):503-504. PubMed ID: 28218231
    [No Abstract]   [Full Text] [Related]  

  • 8. The Impact of Vitiligo on Quality of Life and Psychosocial Well-Being in a Nepalese Population.
    Pun J; Randhawa A; Kumar A; Williams V
    Dermatol Clin; 2021 Jan; 39(1):117-127. PubMed ID: 33228855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitiligo and melanoma-associated hypopigmentation (MAH): shared and discriminative features.
    Hartmann A; Bedenk C; Keikavoussi P; Becker JC; Hamm H; Bröcker EB
    J Dtsch Dermatol Ges; 2008 Dec; 6(12):1053-9. PubMed ID: 18479500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What do Vitiligo Impact Scale-22 scores mean? Studying the clinical interpretation of scores using an anchor-based approach.
    Gupta V; Sreenivas V; Mehta M; Ramam M
    Br J Dermatol; 2019 Mar; 180(3):580-585. PubMed ID: 30085349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Double Strike Hypothesis of the vitiligo pathomechanism: new approaches to vitiligo and melanoma.
    Michelsen D
    Med Hypotheses; 2010 Jan; 74(1):67-70. PubMed ID: 19748188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitiligo impact scale: an instrument to assess the psychosocial burden of vitiligo.
    Krishna GS; Ramam M; Mehta M; Sreenivas V; Sharma VK; Khandpur S
    Indian J Dermatol Venereol Leprol; 2013; 79(2):205-10. PubMed ID: 23442459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long road to valid outcomes in vitiligo.
    Wolkerstorfer A
    Br J Dermatol; 2019 Mar; 180(3):454-455. PubMed ID: 30821367
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessing the minimal important change in the vitiligo extent score and the self-assessment vitiligo extent score.
    Uitentuis SE; Wolkerstorfer A; Bae JM; Esmat S; Mogawer RM; Ragab N; Chuah SY; Passeron T; van Geel N; Thng STG; Terwee CB; Bekkenk MW
    J Am Acad Dermatol; 2021 Nov; 85(5):1363-1364. PubMed ID: 33122021
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of nonsegmental vitiligo on patients' health-related quality of life in the United States.
    Daniel SR; Gandhi K; Anastassopoulos KP; Pandya AG; Sikirica V; Patel R; Napatalung L; Yamaguchi Y; Baik R; Ezzedine K
    Br J Dermatol; 2022 Oct; 187(4):603-606. PubMed ID: 35596712
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychosocial burden of lichen planus pigmentosus is similar to vitiligo, but greater than melasma: A cross-sectional study from a tertiary-care center in north India.
    Gupta V; Yadav D; Satapathy S; Upadhyay A; Mahajan S; Ramam M; Sharma VK
    Indian J Dermatol Venereol Leprol; 2021; 87(3):341-347. PubMed ID: 33943064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitiligo.
    Okoro U; Usatine RP; Heath CR
    Cutis; 2023 Feb; 111(2):106-107. PubMed ID: 37075191
    [No Abstract]   [Full Text] [Related]  

  • 18. Atypical Pattern of Choroidal Hypopigmentation with Cutaneous Vitiligo.
    Kim M; Kwon JW; Park YH
    Korean J Ophthalmol; 2019 Feb; 33(1):99-100. PubMed ID: 30746919
    [No Abstract]   [Full Text] [Related]  

  • 19. Measuring the Impact of Vitiligo: Behind the White Spots.
    Speeckaert R; Lambert J; van Geel N
    J Invest Dermatol; 2016 Jan; 136(1):6-7. PubMed ID: 26763415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hidden victims of childhood vitiligo: impact on parents' mental health and quality of life.
    Amer AA; Mchepange UO; Gao XH; Hong Y; Qi R; Wu Y; Cai Y; Zhai J; Chen HD
    Acta Derm Venereol; 2015 Mar; 95(3):322-5. PubMed ID: 25110968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.